Get the Stockscreener App
34.22
0.61%
-0.21
Harrow Inc stock is traded at $34.22, with a volume of 524.41K.
It is down -0.61% in the last 24 hours and down -19.37% over the past month.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.
See More
Previous Close:
$34.43
Open:
$33.91
24h Volume:
524.41K
Relative Volume:
1.01
Market Cap:
$1.22B
Revenue:
$154.15M
Net Income/Loss:
$-33.58M
P/E Ratio:
-61.11
EPS:
-0.56
Net Cash Flow:
$-20.74M
1W Performance:
-3.61%
1M Performance:
-19.37%
6M Performance:
+71.70%
1Y Performance:
+241.86%
1-Day Range:
$33.75
$35.28
1-Week Range:
$33.27
$37.34
52-Week Range:
$9.13
$59.23
Harrow Inc Stock (HROW) Company Profile
Name
Harrow Inc
Sector
Phone
615.733.4731
Address
102 WOODMONT BLVD, NASHVILLE, CA
Compare HROW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
34.22 | 1.22B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
164.84 | 74.37B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.81B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
22.09 | 25.03B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.52 | 14.94B | 15.05B | -883.30M | 1.89B | -0.74 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-04-24 | Reiterated | B. Riley Securities | Buy |
| Apr-11-24 | Initiated | Craig Hallum | Buy |
| Sep-08-22 | Resumed | B. Riley Securities | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Sep-24-21 | Initiated | Aegis Capital | Buy |
| Jul-02-21 | Initiated | Ladenburg Thalmann | Buy |
View All
Harrow Inc Stock (HROW) Latest News
Harrow’s Valuation Hinges On Lofty Growth Amid Persistent Financial Strains (NASDAQ:HROW) - Seeking Alpha
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires Shares of 32,678 Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow Stock: The Triesence Relaunch (NASDAQ:HROW) - Seeking Alpha
Westside Investment Management Inc. Trims Stock Holdings in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Stifel Financial Corp Has $18.31 Million Stock Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Charles Schwab Investment Management Inc. Boosts Stock Holdings in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Verition Fund Management LLC Acquires Shares of 21,147 Harrow, Inc. (NASDAQ:HROW) - MarketBeat
B. Riley Estimates Harrow's FY2024 Earnings (NASDAQ:HROW) - MarketBeat
BNP Paribas Financial Markets Increases Stock Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow is Now Oversold (HROW) - Nasdaq
Harrow Inc (HROW) Stock Price Down 5.03% on Dec 3 - GuruFocus.com
Quantbot Technologies LP Purchases New Holdings in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Braidwell LP Boosts Stock Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
HROW (Harrow) Profitability Rank : 4 (As of Sep. 2024) - GuruFocus.com
BBR Partners LLC Has $2.79 Million Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Penserra Capital Management LLC Purchases Shares of 44,180 Harrow, Inc. (NASDAQ:HROW) - MarketBeat
US Growth Stocks With High Insider Ownership To Watch - Simply Wall St
Connor Clark & Lunn Investment Management Ltd. Takes $5.86 Million Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow subsidiary wins $34.9 million in trademark case By Investing.com - Investing.com South Africa
Harrow subsidiary wins $34.9 million in trademark case - Investing.com
Harrow’s ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc. - Business Wire
HROW (Harrow) Net Issuance of Preferred Stock : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
Harrow Wins $34.9M Verdict in Major Trademark Infringement Case Against OSRX - StockTitan
HROW (Harrow) Capex-to-Operating-Cash-Flow : 0.20 (As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Cash Flow from Investing : $4.2 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Change In Receivables : $-35.5 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Change In Inventory : $-1.2 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Total Inventories : $10.2 Mil (As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Cash Flow for Dividends : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Long-Term Debt & Capital Lease Obligation : $195.6 Mil (As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Cash Flow from Financing : $-1.5 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Cash Flow from Operations : $4.3 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Operating Cash Flow per Share : $0.12 (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) PE Ratio without NRI : At Loss (As of Nov. 20, 2024) - GuruFocus.com
HROW (Harrow) Total Assets : $351.5 Mil (As of Sep. 2024) - GuruFocus.com
Former Harrow unit Melt announces results for MELT-300 to sedate for surgery - TipRanks
First Turn Management LLC Purchases New Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
28,177 Shares in Harrow, Inc. (NASDAQ:HROW) Purchased by Oppenheimer & Co. Inc. - MarketBeat
Harrow stock plunges 20% on weaker-than-expected Q3 earnings - MSN
Harrow, Inc. (NASDAQ:HROW) Stock Position Lessened by Royce & Associates LP - MarketBeat
Harrow Stock: Spotlight On IHEEZO (NASDAQ:HROW) - Seeking Alpha
Harrow (NASDAQ:HROW) Shares Down 7.3%Here's Why - MarketBeat
Harrow Announces Participation in Upcoming Investor Conferences - BioSpace
Harrow Health, Inc. (NASDAQ:HROW) Q3 2024 Earnings Call Transcript - Insider Monkey
Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Reven - GuruFocus.com
Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... By GuruFocus - Investing.com Canada
Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... - Yahoo Finance
Harrow Inc Com (HROW) Quarterly 10-Q Report - Quartzy
Harrow Grows Revenue 44 Percent in 2024 Third Quarter, Confirms Full-Year Guidance - Vision Monday
Harrow Inc. Reports Strong Q3 2024 Growth - TipRanks
Harrow (NASDAQ:HROW) Shares Gap DownWhat's Next? - MarketBeat
Harrow Inc Stock (HROW) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
1.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):